American International Group, Inc. Crinetics Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$34.76 - $46.81 $1,807 - $2,434	52 Added 0.16%	32,509 $1.52 Million
Q4 2023 Feb 13, 2024	BUY	$25.62 - $37.07 $5,303 - $7,673	207 Added 0.64%	32,457 $1.15 Million
Q3 2023 Nov 13, 2023	BUY	$15.97 - $30.59 $105,162 - $201,435	6,585 Added 25.66%	32,250 $959,000
Q2 2023 Aug 04, 2023	BUY	$15.73 - $23.6 $4,184 - $6,277	266 Added 1.05%	25,665 $462,000
Q1 2023 May 12, 2023	BUY	$15.31 - $21.1 $7,746 - $10,676	506 Added 2.03%	25,399 $407,000
Q4 2022 Feb 10, 2023	SELL	$15.49 - $19.05 $1,409 - $1,733	-91 Reduced 0.36%	24,893 $455,000
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $6,410 - $7,918	354 Added 1.44%	24,984 $491,000
Q2 2022 Aug 12, 2022	BUY	$16.49 - $27.64 $28,841 - $48,342	1,749 Added 7.64%	24,630 $459,000
Q1 2022 May 13, 2022	SELL	$17.15 - $28.31 $27,628 - $45,607	-1,611 Reduced 6.58%	22,881 $502,000
Q4 2021 Feb 11, 2022	BUY	$19.35 - $28.41 $77,651 - $114,009	4,013 Added 19.6%	24,492 $696,000
Q3 2021 Nov 12, 2021	BUY	$16.88 - $25.23 $675 - $1,009	40 Added 0.2%	20,479 $431,000
Q2 2021 Aug 13, 2021	BUY	$15.9 - $21.15 $74,221 - $98,728	4,668 Added 29.6%	20,439 $385,000
Q1 2021 May 07, 2021	BUY	$13.3 - $17.55 $545 - $719	41 Added 0.26%	15,771 $241,000
Q4 2020 Feb 12, 2021	SELL	$12.08 - $17.46 $5,448 - $7,874	-451 Reduced 2.79%	15,730 $222,000
Q3 2020 Nov 04, 2020	SELL	$13.62 - $17.66 $5,012 - $6,498	-368 Reduced 2.22%	16,181 $254,000
Q2 2020 Aug 12, 2020	BUY	$13.04 - $23.23 $130,556 - $232,578	10,012 Added 153.16%	16,549 $290,000
Q1 2020 May 04, 2020	SELL	$11.52 - $26.46 $4,343 - $9,975	-377 Reduced 5.45%	6,537 $96,000
Q4 2019 Feb 05, 2020	SELL	$15.24 - $25.09 $883 - $1,455	-58 Reduced 0.83%	6,914 $173,000
Q3 2019 Nov 08, 2019	SELL	$14.91 - $25.01 $745 - $1,250	-50 Reduced 0.71%	6,972 $105,000
Q2 2019 Aug 13, 2019	BUY	$21.48 - $27.71 $33,165 - $42,784	1,544 Added 28.19%	7,022 $176,000
Q1 2019 May 06, 2019	BUY	$21.07 - $29.31 $18,815 - $26,173	893 Added 19.48%	5,478 $125,000
Q4 2018 Feb 13, 2019	SELL	$22.4 - $35.39 $784 - $1,238	-35 Reduced 0.76%	4,585 $138,000
Q3 2018 Nov 09, 2018	BUY	$22.66 - $36.8 $104,689 - $170,016	4,620 New	4,620 $132,000

Others Institutions Holding CRNX

# of Institutions

242

Shares Held

79.6M

Call Options Held

23.3K

Put Options Held

44.3K

Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$348 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.23M
Shares

$345 Million
0.01% of portfolio
Driehaus Capital Management LLC Chicago, IL

5.89M
Shares

$326 Million
2.95% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.94M
Shares

$274 Million
0.03% of portfolio
Wellington Management Group LLP Boston, MA

4.46M
Shares

$247 Million
0.04% of portfolio

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account